Cargando…

Anthelmintic Drugs as Emerging Immune Modulators in Cancer

Despite recent advances in treatment approaches, cancer is still one of the leading causes of death worldwide. Restoration of tumor immune surveillance represents a valid strategy to overcome the acquired resistance and cytotoxicity of conventional therapies in oncology and immunotherapeutic drugs,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stolfi, Carmine, Pacifico, Teresa, Luiz-Ferreira, Anderson, Monteleone, Giovanni, Laudisi, Federica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094506/ https://www.ncbi.nlm.nih.gov/pubmed/37047419 http://dx.doi.org/10.3390/ijms24076446

Ejemplares similares

Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System
por: Laudisi, Federica, et al.
Publicado: (2020)

Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus Barrier
por: Stolfi, Carmine, et al.
Publicado: (2023)

Impact of Food Additives on Gut Homeostasis
por: Laudisi, Federica, et al.
Publicado: (2019)

Smad7 as a positive regulator of intestinal inflammatory diseases
por: Monteleone, Giovanni, et al.
Publicado: (2023)

STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment
por: Laudisi, Federica, et al.
Publicado: (2018)

Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases
por: Stolfi, Carmine, et al.
Publicado: (2022)

Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms
por: Salvatori, Silvia, et al.
Publicado: (2023)

Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance
por: Monteleone, Giovanni, et al.
Publicado: (2023)

Advances in Immunotherapy and Innovative Therapeutic Approaches for Cancer Treatment: Editorial to the Special Issue “State-of-the-Art Molecular Oncology in Italy”
por: Laudisi, Federica, et al.
Publicado: (2023)

Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells
por: Di Grazia, Antonio, et al.
Publicado: (2020)

Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells
por: Maresca, Claudia, et al.
Publicado: (2022)

Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer
por: Stolfi, Carmine, et al.
Publicado: (2013)

Association Between Celiac Disease and Cancer
por: Marafini, Irene, et al.
Publicado: (2020)

Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer
por: Stolfi, Carmine, et al.
Publicado: (2012)

Colorectal Cancer Chemoprevention by Mesalazine and Its Derivatives
por: Stolfi, Carmine, et al.
Publicado: (2012)

Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer
por: Troncone, Edoardo, et al.
Publicado: (2018)

Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer
por: Troncone, Edoardo, et al.
Publicado: (2021)

Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer
por: Stolfi, Carmine, et al.
Publicado: (2020)

The Dual Role of Inflammation in Colon Carcinogenesis
por: Monteleone, Giovanni, et al.
Publicado: (2012)

Role of T(H)17 cytokines in the control of colorectal cancer
por: De Simone, Veronica, et al.
Publicado: (2013)

Role of Interleukin-34 in Cancer
por: Franzè, Eleonora, et al.
Publicado: (2020)

Smad7 Antisense Oligonucleotide in Crohn’s Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials
por: Monteleone, Giovanni, et al.
Publicado: (2022)

Progranulin sustains STAT3 hyper‐activation and oncogenic function in colorectal cancer cells
por: Laudisi, Federica, et al.
Publicado: (2019)

Viruses in Cancers of the Digestive System: Active Contributors or Idle Bystanders?
por: Marônek, Martin, et al.
Publicado: (2020)

The Dual Role of Smad7 in the Control of Cancer Growth and Metastasis
por: Stolfi, Carmine, et al.
Publicado: (2013)

The Fragile X Mental Retardation Protein Regulates RIPK1 and Colorectal Cancer Resistance to Necroptosis
por: Di Grazia, Antonio, et al.
Publicado: (2020)

Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease
por: Di Grazia, Antonio, et al.
Publicado: (2022)

Interleukin-21 in cancer immunotherapy: Friend or foe?
por: Stolfi, Carmine, et al.
Publicado: (2012)

OC.07.4 RAFOXANIDE INDUCES IMMUNOGENIC DEATH OF COLORECTAL CANCER CELLS
por: Di Grazia, A., et al.
Publicado: (2021)

Expression of Receptors for SARS-CoV-2 in the Gut of Patients with Inflammatory Bowel Disease
por: Monteleone, Giovanni, et al.
Publicado: (2020)

Repurposing of Benzimidazole Anthelmintic Drugs as Cancer Therapeutics
por: Song, Bomi, et al.
Publicado: (2022)

Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death
por: De Simone, Veronica, et al.
Publicado: (2017)

Anthelmintics for drug repurposing: Opportunities and challenges
por: Alavi, Seyed Ebrahim, et al.
Publicado: (2021)

The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation
por: Laudisi, Federica, et al.
Publicado: (2018)

Anthelmintics as Potential Anti-Cancer Drugs?
por: Heo, Dae Seog
Publicado: (2020)

Essential Oils as Novel Anthelmintic Drug Candidates
por: Panda, Sujogya Kumar, et al.
Publicado: (2022)

Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate?
por: Monteleone, Giovanni, et al.
Publicado: (2022)

The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs
por: Son, Deok-Soo, et al.
Publicado: (2020)

Interleukin-34 Enhances the Tumor Promoting Function of Colorectal Cancer-Associated Fibroblasts
por: Franzè, Eleonora, et al.
Publicado: (2020)

Susceptibility of Angiostrongylus cantonensis Larvae to Anthelmintic Drugs
por: Roquini, Daniel B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hpf4kisvs9r4vhhe9rtvllkbe4